Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.31 |
| ▸ | ACE | P12821 | 2/20 | 0.31 |
| ▸ | CPA1 | P15085 | 2/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14224840 | 0.97 | MME (0.30) | MMEACECPA1ACE2 | |
| SCHEMBL18584314 | 0.83 | TSHR (0.40) | TSHR | |
| SCHEMBL18609114 | 0.83 | TSHR (0.40) | TSHR | |
| SCHEMBL10314801 | 0.79 | MME (0.30) | MMEACECPA1ACE2 | |
| SCHEMBL13853470 | 0.77 | METAP1 (0.33) | TSHR | |
| SCHEMBL23207 | 0.76 | — | — | |
| SCHEMBL598937 | 0.75 | TSHR (0.40) | TSHR | |
| SCHEMBL19290491 | 0.75 | TSHR (0.33) | TSHR | |
| SCHEMBL11800096 | 0.73 | TSHR (0.33) | TSHR | |
| SCHEMBL22875963 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11832509-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-11-28 | — | — | US | disclosed |
| WO-2023213801-A1 | PRE-TARGETING | PRECIRIX N.V. (BE) | 2023-11-09 | — | — | WO | disclosed |
| US-11542505-B1 | Substituted RIG-I agonists: compositions and methods thereof | MERCK SHARP & DOHME LLC (US) | 2023-01-03 | — | — | US | disclosed |
| US-20090288221-A1 | Polynucleotides Encoding Canola DHS and Antisense Polynucleotides Thereof | SENESCO TECHNOLOGIES, INC (US) | 2009-11-19 | — | — | US | disclosed |
| US-20090235390-A1 | Isoforms of eIF-5A: senescence-induced eIF-5A; wounding-induced eIF-5A; growth eIF-5A: and DHS | SENESCO TECHNOLOGIES, INC. (US) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542505-B1 | Substituted RIG-I agonists: compositions and methods thereof | MAVS, TLR3, DDX18 | MME 4365/4885ACE 4386/4885CPA1 2855/4885 |
| US-11832509-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | L1CAM, NOM1, MEN1 | MME 4065/4885ACE 3553/4885CPA1 2759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.